BCRX
BioCryst Pharmaceuticals Inc.
$8.31
-$0.16(-1.89%)
48
Overall
--
Value
36
Tech
60
Quality
Market Cap
$1.80B
Volume
2.31M
52W Range
$6.02 - $11.31
Target Price
$16.82
Key Metrics Overview
| Market Cap | $1.80B | P/E Ratio | 92.33 |
| 52W High | $11.31 | 52W Low | $6.02 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 19.6% | 52W Position | 43.3% |
| Overall Score | 48 | Value Score | -- |
| Quality Score | 60 | Technical Score | 36 |
Growth Analysis
| EPS Current Est | $0.09 | EPS Next Est | $0.53 |
| EPS Growth Est | +488.9% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCRX | $8.31 | -1.9% | 2.31M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get BioCryst Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW